# Recodagen Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/recodagen

- Industry: Biotechnology
- Headquarters: Seattle, US
- Total disclosed funding: $1.5M
- Latest round: Series A (Mar 14, 2008)
- Investors on record: 6

## About

Recodagen Corporation is a US-based biotechnology company that develops proteins, and products for the treatment of solid tumors in cancer.

## Funding rounds

- Series A, Mar 14, 2008, $1.5M — ARCH Venture Partners, OVP Venture Partners, Alexandria Venture Investments, Amgen Ventures, WRF Capital, Accelerator Life Science Partners

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A
- OVP Venture Partners (https://capitalatlas.ai/funds/ovp-venture-partners) — Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series A
- WRF Capital (https://capitalatlas.ai/funds/wrf-capital) — Series A
- Accelerator Life Science Partners (https://capitalatlas.ai/funds/accelerator-life-science-partners) — Series A